The FDA issued a formal warning to consumers that hydroxychloroquine and chloroquine -- the antimalarial drugs touted by President Trump as a cure-all for COVID-19 -- should not be used outside of a hospital setting to treat the novel coronavirus.
Read More »New Study Supports Use Of HCQ As Effective Treatment For COVID-19
A study released today supports the use of the malaria drug hydroxychloroquine (HCQ) as a treatment for COVID-19.
Read More »Three Things You Need To Know About COVID-19 If You Have An Autoimmune Condition
The lack of white blood cells prolong the length of time it takes to fight the virus, which causes the symptoms to get worse, and therefore puts those with autoimmune disorders at a higher risk.
Read More »Pharmacists Concerned That Docs, Dentists Are Hoarding Hydroxychloroquine
A family of old antimalarial drugs — including one that some patients rely on to treat their lupus or rheumatoid arthritis — is becoming harder ...
Read More »How To Avoid Coronavirus? Lessons From People Whose Lives Depend On It
Andrea Amelse knows hand-washing. For the past eight years, she’s been washing her hands pretty much every time she passes a sink. When she’s near ...
Read More »Pregnancy Results Good for Women With Controlled Lupus
Not long ago, women with lupus were often told pregnancy was too risky. But new research confirms that when the disease is under control, women ...
Read More »Lupus Death Rates Vary by Race, Ethnicity
THURSDAY, Jan. 15, 2015 (HealthDay News) — Asian and Hispanic lupus patients in the United States have lower death rates than whites, blacks or Native ...
Read More »Study Shows Lupus Patients Suffer in Silence (Infographic)
The Lupus Foundation of America and Eli Lilly and Company released results from a new survey that sheds light on the lupus journey and the ...
Read More »